Navigation Links
Significant Pre-Clinical Data in Acute Lung Injury
Date:9/9/2012

The Company possesses multiple proprietary siRNA delivery technology platforms including AtuPLEX™, DACC and DBTC. AtuPLEX enables the broad functional delivery of siRNA molecules to targeted diseased tissues and cells, while increasing their bioavailability and intracellular uptake. The DACC delivery system allows functional delivery of siRNA molecules selectively to the lung endothelium with a long duration of target mRNA and protein knock-down. The DBTC delivery system enables functional delivery of siRNA molecules selectively to liver cells including hepatocytes. Additionally, the Company has a platform of novel siRNA molecules based around its AtuRNAi chemical modification technology, which provides a number of advantages over conventional siRNA molecules. Silence's unique RNAi assets also include structural features for RNAi molecules and specific design rules for increased potency and reduced off-target effects of siRNA sequences.

The Company's lead internal drug candidate is Atu027, a liposomal formulation in clinical development for systemic cancer indications and one of the most clinically advanced RNAi therapeutic candidates in the area of oncology. Atu027 incorporates two of the Company's technologies, AtuRNAi and AtuPLEX. Silence is currently conducting an open-label, single-centre, dose-escalation Phase I study with Atu027 in patients with advanced solid tumors involving single, as well as repeated, intravenous administration. Encouraging interim safety and pharmacokinetic data were presented at the American Society of Clinical Oncology Annual Meeting in June 2011. The study is expected to be completed in the first half of 2012.

The Company's RNAi therapeutic platform has received key validation through multiple partnerships with pharmaceutical companies including AstraZeneca, Dainippon Sumitomo, Pfizer/Quark, and Novartis/Quark. Silence is actively pursuing the establishment of additional partnerships. Silence The
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research
2. Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com
3. Patient Advocate Foundation Receives Significant Support to Aid Non-Squamous Non-Small Cell Lung Cancer Patients through the Co-Pay Relief Program
4. Cambrex Announces Significant New Supply Agreement
5. Wound Care Management Market to 2018 - Advanced Wound Care Modalities and an Expanding Patient Base Create Significant Growth Opportunities in Emerging Countries
6. Huntzinger Management Group, Inc., (HMG) Reporting Significant Growth in 2012
7. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
8. North Dakotas Stop-Sale System Achieves Significant Results In Battle Against Meth
9. Floridas Stop-Sale System Achieves Significant Results In Battle Against Meth
10. Nebraska Stop-Sale System Achieves Significant Results In Battle Against Meth
11. Texas Stop-Sale System Achieves Significant Results In Battle Against Meth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... previously announced registered offering of common shares in ... to the Offering, the Company issued 7,286,432 common shares ... gross proceeds of approximately $1.45 billion. On March 18, ... Exchange Commission a final prospectus supplement to its effective ...
(Date:3/27/2015)... 2015 As of February, InControl Medical, ... for women. "Shipping thousands of our ... is the hundreds of letters, emails and phone ... been positively impacted by our technology," said ... InControl recently released Apex, an over-the-counter solution for ...
(Date:3/27/2015)...   Hospira, Inc. (NYSE: HSP ... world,s leading provider of injectable drugs and infusion ... of biosimilarity of its proposed biosimilar, Epoetin Hospira, ... conditionally approved name of RETACRIT™, compared to the ... data were presented at the National Kidney Foundation ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
... Feb. 2, 2011 DRIVE4COPD today announced that it achieved ... risk for chronic obstructive pulmonary disease (COPD) in its first ... change in how COPD is addressed in this country and ... millions who may be at risk for COPD and do ...
... 2, 2011 Reportlinker.com announces that a new ... Global Pipettes and Pipettors Industry ... This report analyzes the worldwide markets for Pipettes ... by the following product segments: Electronic Pipettors, Mechanical ...
Cached Medicine Technology:DRIVE4COPD Moves 1 Million People to Get Screened and Determine Personal COPD Risk in First Year 2DRIVE4COPD Moves 1 Million People to Get Screened and Determine Personal COPD Risk in First Year 3DRIVE4COPD Moves 1 Million People to Get Screened and Determine Personal COPD Risk in First Year 4DRIVE4COPD Moves 1 Million People to Get Screened and Determine Personal COPD Risk in First Year 5DRIVE4COPD Moves 1 Million People to Get Screened and Determine Personal COPD Risk in First Year 6Global Pipettes and Pipettors Industry 2Global Pipettes and Pipettors Industry 3Global Pipettes and Pipettors Industry 4Global Pipettes and Pipettors Industry 5Global Pipettes and Pipettors Industry 6Global Pipettes and Pipettors Industry 7Global Pipettes and Pipettors Industry 8Global Pipettes and Pipettors Industry 9Global Pipettes and Pipettors Industry 10Global Pipettes and Pipettors Industry 11Global Pipettes and Pipettors Industry 12Global Pipettes and Pipettors Industry 13Global Pipettes and Pipettors Industry 14Global Pipettes and Pipettors Industry 15Global Pipettes and Pipettors Industry 16Global Pipettes and Pipettors Industry 17Global Pipettes and Pipettors Industry 18Global Pipettes and Pipettors Industry 19Global Pipettes and Pipettors Industry 20Global Pipettes and Pipettors Industry 21Global Pipettes and Pipettors Industry 22Global Pipettes and Pipettors Industry 23Global Pipettes and Pipettors Industry 24Global Pipettes and Pipettors Industry 25Global Pipettes and Pipettors Industry 26
(Date:3/28/2015)... (PRWEB) March 28, 2015 Centurion Service Group ... auction on Thursday, April 2 at their Las Vegas warehouse, ... NV 89081. The sale, which consists of equipment from hospitals ... promptly at 9 a.m. PDT. , Buyers will find ... surgery equipment. “We are a one-stop-shop,” said Erik Tivin, CEO ...
(Date:3/28/2015)... How best to treat and recover ... orthopaedic medicine. While diagnostic hip injections are commonly performed ... etiology, research presented today at the American Orthopaedic Society ... that pain relief from this diagnostic injection may not ... “Our study looked to assess if the amount of ...
(Date:3/28/2015)... Genomic medicine experts have sequenced the genomes ... first time, key information for understanding and treating this ... posted story on the Surviving Mesothelioma website. ... the British Columbia Cancer Agency, and PhenoPath lab in ... alterations and mutations that can lead to peritoneal ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
(Date:3/28/2015)... 28, 2015 Designers and Professionals of ... entitled Scratches 5K from Pixel Film Studios. , “Scratches ... any media inside Final Cut Pro X” Said Christina ... time and is an effective tool for any FCPX ... Scratches 5K's intuitive grunge overlays. Simply drag title layers ...
Breaking Medicine News(10 mins):Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2
... from Sheffield University most women still believe one-night stands ... revealed that women of all ages believe that sex ... ,The women community despite achieving liberation still feels ... of desperation or drunkenness. The research which was followed ...
... prevented in cancer patients, as a new method of delivering ... side effects such as hair loss and vomiting to the ... Bath, England, involves using tiny fibres and beads soaked in ... area in the patient's body. ,These fibres ...
... the Federal Government would provide $47,000 as funding for ... money would help the community health care provider. This ... transitional period. Health services play a major and integral ... that up with financial support. Due to lack of ...
... suspected of spreading the deadly bird flu in Israel. This ... agriculture department. ,'It's one of our working hypotheses. ... of cars and even on cameras. The journalists who came ... offices across the country,' said the health official. ...
... student of psychology is planning to record the barks and growls ... canines communicate//. ,Anna Taylor, 23, of Brighton in southern England, ... and sizes to take part in the study, it was reported ... the dogs to bark and growl including banging on doors and ...
... peptide can predict the presence of pulmonary hypertension in ... appearing in the April issue of the American //Journal ... American Thoracic Society. ,Juergen Behr, M.D., of the ... medicine at Ludwig Maximillians University in Munich, Germany, and ...
Cached Medicine News:Health News:New Method Developed To Cut Down Chemotherapy Deaths 2
... Balloon Ultra device consists of a non-compliant ... blades) mounted longitudinally on its outer surface. ... inflated, the atherotomes score the plaque, creating ... referred to as Atherotomy, allows dilatation of ...
... Dual Pressure Sensor Intravascular Mikro-Tip Pressure ... line of dual pressure sensor catheters ... These catheters are suitable for measuring ... chambers, or across a vascular stenosis. ...
... pressure sensor catheters incorporate a ... injection/guide wire, or high-speed injection/guide ... high-speed injection has two laterally ... an open-end pigtail extension for ...
... Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; ... of dual pressure sensor catheters for ... catheters are suitable for measuring pressure ... or across a vascular stenosis. The ...
Medicine Products: